Remove Dosage Remove Labelling Remove Packaging
article thumbnail

Labelling of Dispensed Medicine

RX Note

Labelling Requirements A ll dispensed medicine should be labelled according to the requirement stated by the law. NOTE: It is advisable for labels to be printed. Consequently, a patient-centred label strategy is introduced to promote appropriate medication use and adherence. fever, cough or cold).

article thumbnail

Labetalol batch recalled due to wrong dosage labelling

The Pharmacist

A batch of Labetalol 200mg tablets has been recalled as they are incorrectly labelled as 100mg tablets on the foil blister packaging. Pharmacists have been instructed to immediately stop […] The post Labetalol batch recalled due to wrong dosage labelling appeared first on The Pharmacist.

Dosage 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sustainability continues to steer pharmaceutical packaging market

European Pharmaceutical Review

The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion by 2033, according to a study published by Towards Packaging. Specifically, the “high quality of biodegradable and recyclable packaging materials” are driving the market. billion in 2025 to approximately $174.45

article thumbnail

Sustainable pharma packaging: breaking down the barriers to adoption

European Pharmaceutical Review

For most consumers, product packaging represents their first impression of a brand and its sustainability credentials. But how is this push shaping the pharma packaging market and what are the key changes we can expect to see? For many, aesthetic appeal and user experience top the list of priorities when it comes to packaging design.

article thumbnail

Navigating the Generic Drug Approval Process: A Comprehensive Guide

Drug Patent Watch

Step 2: ANDA Filing Generic drug manufacturers submit an Abbreviated New Drug Application (ANDA) to the FDA, which includes detailed information about the proposed generic drug, including its active ingredients, dosage forms, and manufacturing processes. This includes providing clear instructions for use, warnings, and precautions.

article thumbnail

Overcoming regulatory issues with investigational medicinal product labelling 

Pharmaceutical Technology

Issues with regulatory requirements and documentation can also cause significant delays, while any inaccuracies in translations on labelling can mean that dosage and storage information is not correctly understood or followed. And accurate labelling and translation are critical for this sector.

article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

IPA also pointed out that US regulations require adverse events related to any dosage form of a drug to be reported under the same Abbreviated New Drug Application (ANDA) number, even if the product is manufactured at a different facility or outside India. Thus, it cannot be conclusively linked with the manufacturing site or manufacturers.